() Kinapharma Ghana Limited is considering investing GH20 Million today to fund research into new Malaria drugs in Africa. The company estimates that the project will make profit of GH Million per year starting 5 years from now for 15 continuous years, after which it will no longer be profitable due to loss of patent right. Determine the no- return payback period for a quick evaluation of economic viability